| 000 | 01855 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250513053332.0 | ||
| 264 | 0 | _c19941128 | |
| 008 | 199411s 0 0 eng d | ||
| 022 | _a0093-7754 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVokes, E E | |
| 245 | 0 | 0 |
_aA phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design. _h[electronic resource] |
| 260 |
_bSeminars in oncology _cOct 1994 |
||
| 300 |
_a79-83; discussion 83-4 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAgranulocytosis _xchemically induced |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadministration & dosage |
| 650 | 0 | 4 |
_aBone Marrow _xdrug effects |
| 650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
| 650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
| 650 | 0 | 4 | _aCohort Studies |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFluorouracil _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeucovorin _xadministration & dosage |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aRemission Induction |
| 650 | 0 | 4 |
_aVinblastine _xadministration & dosage |
| 650 | 0 | 4 | _aVinorelbine |
| 700 | 1 | _aDrinkard, L C | |
| 700 | 1 | _aSamuels, B L | |
| 700 | 1 | _aHoffman, P C | |
| 700 | 1 | _aWatson, S | |
| 700 | 1 | _aBitran, J D | |
| 700 | 1 | _aHaraf, D J | |
| 700 | 1 | _aFerguson, M F | |
| 700 | 1 | _aGolomb, H M | |
| 773 | 0 |
_tSeminars in oncology _gvol. 21 _gno. 5 Suppl 10 _gp. 79-83; discussion 83-4 |
|
| 999 |
_c7973106 _d7973106 |
||